Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Pathogenesis and management of essential thrombocythemia Beer PA; Green ARHematology Am Soc Hematol Educ Program 2009[]; ä (ä): 621-8The last four years have seen an explosion in our understanding of the myeloproliferative neoplasms. Important and often unexpected insights into the molecular mechanisms responsible for these disorders have been accompanied by the development of new diagnostic tests and by an improved understanding of the relationship between the different disease entities. This review will focus on recent developments in the pathogenesis and management of essential thrombocythemia with a particular emphasis on its phenotypic overlap with polycythemia vera and primary myelofibrosis.|Acute Disease[MESH]|Aged[MESH]|Aspirin/therapeutic use[MESH]|Clone Cells/pathology[MESH]|Disease Management[MESH]|Disease Progression[MESH]|Humans[MESH]|Hydroxyurea/therapeutic use[MESH]|Interferon-alpha/therapeutic use[MESH]|Janus Kinase 2/antagonists & inhibitors/genetics/physiology[MESH]|Leukemia, Myeloid/pathology[MESH]|Middle Aged[MESH]|Models, Biological[MESH]|Mutation, Missense[MESH]|Polycythemia Vera/diagnosis[MESH]|Primary Myelofibrosis/diagnosis[MESH]|Prognosis[MESH]|Protein Kinase Inhibitors/therapeutic use[MESH]|Quinazolines/therapeutic use[MESH]|Thrombocythemia, Essential/diagnosis/drug therapy/*etiology/genetics/pathology[MESH]|Thrombophilia/drug therapy/etiology[MESH] |
